- Report
- November 2025
- 150 Pages
Global
From €5279EUR$5,950USD£4,597GBP
- Report
- October 2025
- 150 Pages
Global
From €5279EUR$5,950USD£4,597GBP
- Report
- May 2025
- 190 Pages
Global
From €5279EUR$5,950USD£4,597GBP
- Report
- January 2026
- 291 Pages
Global
From €2218EUR$2,500USD£1,931GBP
- Report
- January 2026
- 181 Pages
Global
From €3145EUR$3,545USD£2,739GBP
€3495EUR$3,939USD£3,043GBP
- Report
- August 2025
- 188 Pages
Global
From €3145EUR$3,545USD£2,739GBP
€3495EUR$3,939USD£3,043GBP
- Report
- August 2025
- 185 Pages
Global
From €3992EUR$4,500USD£3,476GBP
- Report
- January 2026
- 185 Pages
Global
From €3992EUR$4,500USD£3,476GBP
- Report
- January 2026
- 186 Pages
Global
From €3145EUR$3,545USD£2,739GBP
€3495EUR$3,939USD£3,043GBP
- Report
- February 2026
- 250 Pages
Global
From €3984EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €3984EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €3984EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €3984EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €3984EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €3984EUR$4,490USD£3,469GBP
- Report
- April 2026
- 382 Pages
Global
From €5190EUR$5,850USD£4,519GBP
- Report
- April 2026
- 292 Pages
Global
From €5190EUR$5,850USD£4,519GBP
- Report
- April 2026
- 287 Pages
Global
From €5190EUR$5,850USD£4,519GBP
- Report
- April 2026
- 1417 Pages
Global
From €5190EUR$5,850USD£4,519GBP
- Report
- April 2026
- 158 Pages
Global
From €5190EUR$5,850USD£4,519GBP

Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate between SARS and other respiratory illnesses.
Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution.
Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more